Search results
1 – 10 of 26
Progress was made on the technical details of Pillar 1, the reallocation of taxing rights from host countries to those where a multinational operates, but US opposition has…
Details
DOI: 10.1108/OXAN-DB275316
ISSN: 2633-304X
Keywords
Geographic
Topical
The 'Panama papers' disclosures brought attention to the weak harmonisation of corporate tax policies, creating loopholes that can be exploited to avoid and evade tax. The…
Details
DOI: 10.1108/OXAN-DB211043
ISSN: 2633-304X
Keywords
Geographic
Topical
This marks another step towards Panama’s long-standing aim of strengthening its fiscal framework and countering its reputation as a tax haven. While the law will bring some…
Details
DOI: 10.1108/OXAN-DB265772
ISSN: 2633-304X
Keywords
Geographic
Topical
The fallout from the 'Panama Papers'.
Details
DOI: 10.1108/OXAN-DB210638
ISSN: 2633-304X
Keywords
Geographic
Topical
Malta is one of several EU member states recently involved in allegations of money laundering. Prime Minister Joseph Muscat is under pressure, not least in the European…
Details
DOI: 10.1108/OXAN-DB240357
ISSN: 2633-304X
Keywords
Geographic
Topical
The Commission judged that Irish authorities had forgone this sum as part of a special arrangement with the global technology company, thereby granting it illegal state aid. This…
Details
DOI: 10.1108/OXAN-DB213509
ISSN: 2633-304X
Keywords
Geographic
Topical
The impact of the diverted profits tax.
Details
DOI: 10.1108/OXAN-DB200507
ISSN: 2633-304X
Keywords
Geographic
Topical
The rulings come as the EU advances legislation to increase transparency on corporate tax rulings and after the G20 on October 9 endorsed the new OECD Base Erosion and Profit…
Details
DOI: 10.1108/OXAN-DB206131
ISSN: 2633-304X
Keywords
Geographic
Topical
On October 16, Daphne Caruana Galizia, a Maltese journalist, was killed in a car bombing outside her home. Her murder has renewed concerns about law and order, democracy and press…
Details
DOI: 10.1108/OXAN-DB225299
ISSN: 2633-304X
Keywords
Geographic
Topical
Outlook for healthcare and pharmaceutical M&A.